162 related articles for article (PubMed ID: 21296677)
1. Heat shock protein 104 inhibited the fibrillization of prion peptide 106-126 and disassembled prion peptide 106-126 fibrils in vitro.
Liu YH; Han YL; Song J; Wang Y; Jing YY; Shi Q; Tian C; Wang ZY; Li CP; Han J; Dong XP
Int J Biochem Cell Biol; 2011 May; 43(5):768-74. PubMed ID: 21296677
[TBL] [Abstract][Full Text] [Related]
2. Altered toxicity of the prion protein peptide PrP106-126 carrying the Ala(117)-->Val mutation.
Brown DR
Biochem J; 2000 Mar; 346 Pt 3(Pt 3):785-91. PubMed ID: 10698707
[TBL] [Abstract][Full Text] [Related]
3. Zinc, copper, and carnosine attenuate neurotoxicity of prion fragment PrP106-126.
Kawahara M; Koyama H; Nagata T; Sadakane Y
Metallomics; 2011 Jul; 3(7):726-34. PubMed ID: 21442127
[TBL] [Abstract][Full Text] [Related]
4. Highly accelerated self-assembly and fibrillation of prion peptides on solid surfaces.
Ku SH; Park CB
Langmuir; 2008 Dec; 24(24):13822-7. PubMed ID: 19053635
[TBL] [Abstract][Full Text] [Related]
5. Interaction between 14-3-3β and PrP influences the dimerization of 14-3-3 and fibrillization of PrP106-126.
Han J; Song QQ; Sun P; Zhang J; Wang X; Song J; Li GQ; Liu YH; Mei GY; Shi Q; Tian C; Chen C; Gao C; Zhao B; Dong XP
Int J Biochem Cell Biol; 2014 Feb; 47():20-8. PubMed ID: 24269782
[TBL] [Abstract][Full Text] [Related]
6. Core structure of amyloid fibrils formed by residues 106-126 of the human prion protein.
Walsh P; Simonetti K; Sharpe S
Structure; 2009 Mar; 17(3):417-26. PubMed ID: 19278656
[TBL] [Abstract][Full Text] [Related]
7. Molecular dynamics study of the fibril elongation of the prion protein fragment PrP106-126.
Zhang Y; Zhao X; Wang PY
J Theor Biol; 2007 Mar; 245(2):238-42. PubMed ID: 17166520
[TBL] [Abstract][Full Text] [Related]
8. Aspirin inhibits cytotoxicity of prion peptide PrP106-126 to neuronal cells associated with microglia activation in vitro.
Yang L; Zhou X; Yang J; Yin X; Han L; Zhao D
J Neuroimmunol; 2008 Aug; 199(1-2):10-7. PubMed ID: 18547651
[TBL] [Abstract][Full Text] [Related]
9. Prion protein fragment 106-126 induces a p38 MAP kinase-dependent apoptosis in SH-SY5Y neuroblastoma cells independently from the amyloid fibril formation.
Corsaro A; Thellung S; Villa V; Principe DR; Paludi D; Arena S; Millo E; Schettini D; Damonte G; Aceto A; Schettini G; Florio T
Ann N Y Acad Sci; 2003 Dec; 1010():610-22. PubMed ID: 15033801
[TBL] [Abstract][Full Text] [Related]
10. p75(NTR) activation of NF-kappaB is involved in PrP106-126-induced apoptosis in mouse neuroblastoma cells.
Bai Y; Li Q; Yang J; Zhou X; Yin X; Zhao D
Neurosci Res; 2008 Sep; 62(1):9-14. PubMed ID: 18602709
[TBL] [Abstract][Full Text] [Related]
11. Small stress molecules inhibit aggregation and neurotoxicity of prion peptide 106-126.
Kanapathipillai M; Ku SH; Girigoswami K; Park CB
Biochem Biophys Res Commun; 2008 Jan; 365(4):808-13. PubMed ID: 18039468
[TBL] [Abstract][Full Text] [Related]
12. Clustered negative charges on the lipid membrane surface induce beta-sheet formation of prion protein fragment 106-126.
Miura T; Yoda M; Takaku N; Hirose T; Takeuchi H
Biochemistry; 2007 Oct; 46(41):11589-97. PubMed ID: 17887730
[TBL] [Abstract][Full Text] [Related]
13. Hsp104 catalyzes formation and elimination of self-replicating Sup35 prion conformers.
Shorter J; Lindquist S
Science; 2004 Jun; 304(5678):1793-7. PubMed ID: 15155912
[TBL] [Abstract][Full Text] [Related]
14. Oxidation reduces the fibrillation but not the neurotoxicity of the prion peptide PrP106-126.
Bergström AL; Chabry J; Bastholm L; Heegaard PM
Biochim Biophys Acta; 2007 Sep; 1774(9):1118-27. PubMed ID: 17707142
[TBL] [Abstract][Full Text] [Related]
15. Amyloid aggregates of the prion peptide PrP106-126 are destabilised by oxidation and by the action of dendrimers.
Heegaard PM; Pedersen HG; Flink J; Boas U
FEBS Lett; 2004 Nov; 577(1-2):127-33. PubMed ID: 15527773
[TBL] [Abstract][Full Text] [Related]
16. Molecular determinants of the physicochemical properties of a critical prion protein region comprising residues 106-126.
Salmona M; Malesani P; De Gioia L; Gorla S; Bruschi M; Molinari A; Della Vedova F; Pedrotti B; Marrari MA; Awan T; Bugiani O; Forloni G; Tagliavini F
Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):207-14. PubMed ID: 10432318
[TBL] [Abstract][Full Text] [Related]
17. A neurotoxic and gliotrophic fragment of the prion protein increases plasma membrane microviscosity.
Salmona M; Forloni G; Diomede L; Algeri M; De Gioia L; Angeretti N; Giaccone G; Tagliavini F; Bugiani O
Neurobiol Dis; 1997; 4(1):47-57. PubMed ID: 9258911
[TBL] [Abstract][Full Text] [Related]
18. Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro.
Tagliavini F; Forloni G; Colombo L; Rossi G; Girola L; Canciani B; Angeretti N; Giampaolo L; Peressini E; Awan T; De Gioia L; Ragg E; Bugiani O; Salmona M
J Mol Biol; 2000 Jul; 300(5):1309-22. PubMed ID: 10903871
[TBL] [Abstract][Full Text] [Related]
19. Copper and zinc binding modulates the aggregation and neurotoxic properties of the prion peptide PrP106-126.
Jobling MF; Huang X; Stewart LR; Barnham KJ; Curtain C; Volitakis I; Perugini M; White AR; Cherny RA; Masters CL; Barrow CJ; Collins SJ; Bush AI; Cappai R
Biochemistry; 2001 Jul; 40(27):8073-84. PubMed ID: 11434776
[TBL] [Abstract][Full Text] [Related]
20. Influence of phosphorus dendrimers on the aggregation of the prion peptide PrP 185-208.
Klajnert B; Cortijo-Arellano M; Cladera J; Majoral JP; Caminade AM; Bryszewska M
Biochem Biophys Res Commun; 2007 Dec; 364(1):20-5. PubMed ID: 17927954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]